Katie Bain, Eric Renner Brown, Anna Chan, Frank DiGiacomo, Thom Duffy, Jason Lipshutz, Joe Lynch, Rebecca Milzoff, Glenn Peoples, Isabela Raygoza, Andrew Unterberger Feb 11, 2025 12:01 pm Record ...

Alphabet has gained about 9% so far this year. Wall Street had been expecting 2025 capital expenditures of about $58 billion, according to LSEG data. That would have marked a modest increase over ...

Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investment Bain Capital ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes and cancer with “precision medicine”. Leverage the power of TipRanks ...

Bain Capital is making its latest biotech bid in Japan, where it plans to acquire Mitsubishi Tanabe Pharma Corp. The Boston-based private investment firm is buying Tanabe Pharma from Mitsubishi ...

Commissions do not affect our editors' opinions or evaluations. Capital One combines the convenience of online banking with the features of a traditional bank. It’s known for its competitive ...

Batesville, Ind.-based Hillenbrand Inc. is selling the majority of its Milacron injection molding and extrusion business to an affiliate of Bain Capital for $287 million. The sale of 51 percent of ...

Investment to accelerate Milacron’s growth and strengthen its position as a global leader in highly engineered plastic processing solutions. Milacron’s comprehensive suite of equipment ...

the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection molding and extrusion business to an affiliate of Bain Capital for $287M ...

matching the $3.1 billion offer in the market from private equity rivals Bain Capital and CC Capital. Brookfield’s bid, at $4.60 a share, also allows for some Insignia shareholders to stay ...

1 Day BCSF 0.00% DJIA -0.75% S&P Mid Cap 400 -0.90% Financial Services -0.65% ...

Bain Capital is making a play for full control of Surgery Partners (NASDAQ:SGRY), throwing down a $25.75 per share all-cash offervaluing the surgical facility operator at $3.2 billion. With Bain ...